LifeMD LFMDP
NASDAQ LFMDP
$23.17 0.00 (-0.02%)
As of: Aug 21, 2026 · 3:44 PM EDT

LifeMD, Inc. (LFMDP) Asset Writedowns and Impairment (2016 - 2020)

LifeMD's (LFMDP) quarterly Asset Writedowns and Impairment came in at $74530.0 in Q4 2020, up 1728.72% on a QoQ basis from -$4576.0 in Q3 2017.

LifeMD, Inc. (LFMDP) Asset Writedowns and Impairment (2016 - 2020) Analysis & Trends

LifeMD (LFMDP) has 3 years of Asset Writedowns and Impairment data on file, last reported at $74530.0 in Q4 2020.

  • Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $74530.0 in Q4 2020, while the trailing twelve-month figure through Dec 2021 was $74530.0 (up 17.48% YoY) and the FY2024 annual result came in at $675669.0, up 25.66% from the prior year.
  • Asset Writedowns and Impairment grew to $74530.0 in Q4 2020, from -$4576.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $114694.0 in Q4 2016 to a low of -$38027.0 in Q1 2017.
  • A 3-year average of $28021.0 and a median of -$4576.0 in 2017 frame the typical range for Asset Writedowns and Impairment.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2020 74,530.00
Dec 31, 2020 74,530.00
Sep 30, 2017 -4,576.00
Sep 30, 2017 -4,576.00
Jun 30, 2017 -6,516.00
Jun 30, 2017 -6,516.00
Mar 31, 2017 -38,027.00
Mar 31, 2017 -38,027.00
Dec 31, 2016 114,694.00
Dec 31, 2016 114,694.00